Shehab, H. M., & Yasmin, H. (2024). A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine. Brac University.
Lua i Stíl Chicago (17ú heag.)Shehab, Habibul Mohsin, agus Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
Lua MLA (8ú heag.)Shehab, Habibul Mohsin, agus Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.